Document is current
Any future updates will be listed below
-
Authors
Hoyer-Kimura, Christina https://orcid.org/0000-0003-4400-2529
Konhilas, John P.
Mansour, Heidi M.
Polt, Robin
Doyle, Kristian P.
Billheimer, Dean
Hay, Meredith
-
Funding
Funding for this research was provided by:
National Institute on Aging (NIA U01AG066623-01)
- License Information
-
More Information
Article History
Received: 29 March 2021
Accepted: 20 September 2021
First Online: 15 October 2021
Declarations
:
: All procedures, handling, and treatments were approved by the institutional Animal Care and Use Committee at the University of Arizona in agreement with the National Institute of Health Guidelines for the care and Use of Laboratory Animals.
: Not applicable.
: COI, Dr. Meredith Hay is the founder of ProNeurogen, Inc. that holds exclusive rights to the clinical development of the Ang-(1–7)/MasR agonists described herein.
